TAK-901

· Millennium Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TAK-901, covering 2011-12-08 to 2013-07-02. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies [Phase 1]